| Literature DB >> 33239730 |
Łukasz Szelerski1, Andżelika Pajchert-Kozłowska2, Sławomir Żarek3, Radosław Górski3, Paweł Małdyk3, Piotr Morasiewicz2,4.
Abstract
Nonunions of the tibia, particularly those located in the distal third of the bone, are relatively common in clinical practice. There is no gold standard for the treatment of nonunions of the tibia. The purpose of our study was to assess the results of treatment with the Ilizarov method in patients with aseptic nonunions of the tibia, depending on the employed treatment strategies and surgical techniques. A total of 75 patients with Ilizarov treatment of aseptic nonunions of the tibia were evaluated in the study. The patients's mean age at the beginning of treatment was 46 years. The mean follow-up period was 10 years and 11 months. The evaluated patients underwent either closed technique or open technique. The operators used one of two treatment strategies: neutral fixation without compression or continued compression. The following were assessed: rates of union, ASAMI bone scores, ASAMI functional scores, treatment time, complications, duration of hospital stay. Bone union was achieved in all of the 75 evaluated patients. The results of most analyses showed no significant differences in the assessed variables, except for the ASAMI functional scores, which were higher in the group of patients who underwent closed surgery (Me = 6.00 vs. Me = 4.00). We observed better ASAMI functional score outcomes in the patients who underwent closed fixation than in the open fixation group. The different surgical techniques and treatment strategies had no effect on the number of complications, rates of bone union, length of hospital stay, duration of Ilizarov treatment, or ASAMI bone scores. For managing nonunions of the tibia we recommend the technique of closed fixation without continued compression. The Ilizarov method in the treatment of nonunions of the tibia gives good outcomes.Entities:
Mesh:
Year: 2020 PMID: 33239730 PMCID: PMC7689488 DOI: 10.1038/s41598-020-77569-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Hypertrophic non-union of 1/3 distal tibia a–p view.
Figure 2Hypertrophic non-union of 1/3 distal tibia treated by Ilizarov External Fixator (a–p view).
Figure 3Hypertrophic non-union of 1/3 distal tibia treated by Ilizarov External Fixator (lateral view).
Descriptive statistics and Shapiro–Wilk test results for quantitative variables in the patients who underwent open fixation procedures (n = 27).
| Kurt | Min | Max | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Length of hospital stay (days) | 15.89 | 11.00 | 9.35 | 1.15 | 0.68 | 4.00 | 39.00 | 0.87 | 0.003 |
| Ilizarov treatment duration (days) | 251.11 | 218.00 | 150.29 | 2.16 | 6.62 | 83.00 | 810.00 | 0.82 | < 0.001 |
| ASAMI bone score | 9.11 | 10.00 | 2.56 | − 2.62 | 5.27 | 2.00 | 10.00 | 0.37 | < 0.001 |
| ASAMI functional score | 4.89 | 4.00 | 1.01 | 0.24 | − 2.11 | 4.00 | 6.00 | 0.63 | < 0.001 |
| Number of complications | 0.44 | 0.00 | 0.64 | 1.17 | 0.40 | 0.00 | 2.00 | 0.69 | < 0.001 |
M mean, Me median, SD standard deviation, Sk. skewness, Kurt., kurtosis, Min minimum, Max maximum, S–W Shapiro–Wilk test result, p-value significance of normality of distribution.
Descriptive statistics and Shapiro–Wilk test results for quantitative variables in the patients who underwent closed fixation procedures (n = 48).
| Kurt | Min | Max | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Length of hospital stay (days) | 14.40 | 10.50 | 11.86 | 2.48 | 8.10 | 4.00 | 68.00 | 0.74 | < 0.001 |
| Ilizarov treatment duration (days) | 226.40 | 192.50 | 115.86 | 1.82 | 3.67 | 84.00 | 630.00 | 0.82 | < 0.001 |
| ASAMI bone score | 9.13 | 10.00 | 2.61 | − 2.73 | 5.85 | 0.00 | 10.00 | 0.36 | < 0.001 |
| ASAMI functional score | 5.42 | 6.00 | 1.16 | − 2.58 | 8.78 | 0.00 | 6.00 | 0.53 | < 0.001 |
| Number of complications | 0.27 | 0.00 | 0.49 | 1.60 | 1.76 | 0.00 | 2.00 | 0.57 | < 0.001 |
M mean, Me median, SD standard deviation, Sk. skewness, Kurt. kurtosis, Min minimum, Max maximum, S–W Shapiro–Wilk test result, p-value significance of normality of distribution.
Mann–Whitney U test results for selected quantitative variables, stratified by the surgical technique (open vs. closed) (N = 75).
| Length of hospital stay (days) | 516.00 | − 1.46 | 0.145 | 0.03 |
| Ilizarov treatment duration (days) | 576.50 | − 0.78 | 0.433 | 0.01 |
| ASAMI bone score | 645.00 | 0.05 | 0.959 | < 0.01 |
| ASAMI functional score | 0.08 | |||
| Number of complications | 563.00 | − 1.17 | 0.240 | 0.02 |
U and Z Mann–Whitney U test statistics, p-value level of significance, η2 (eta-squared) a measure of effect size for Mann–Whitney U test.
Descriptive statistics and Shapiro–Wilk test results for quantitative variables in the patients who underwent Ilizarov treatment with no compression, n = 38).
| Kurt | Min | Max | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Length of hospital stay (days) | 15.34 | 11.00 | 10.61 | 1.21 | 0.22 | 4.00 | 39.00 | 0.81 | < 0.001 |
| Ilizarov treatment duration (days) | 255.03 | 204.00 | 155.94 | 1.90 | 3.92 | 84.00 | 810.00 | 0.80 | < 0.001 |
| ASAMI bone score | 8.68 | 10.00 | 3.09 | − 2.00 | 2.21 | 0.00 | 10.00 | 0.45 | < 0.001 |
| ASAMI functional score | 5.16 | 6.00 | 1.28 | − 1.93 | 5.42 | 0.00 | 6.00 | 0.63 | < 0.001 |
| Number of complications | 0.32 | 0.00 | 0.53 | 1.40 | 1.13 | 0.00 | 2.00 | 0.61 | < 0.001 |
M mean, Me median, SD standard deviation, Sk. skewness, Kurt. kurtosis, Min minimum, Max maximum, S–W Shapiro–Wilk test result, p-value significance of normality of distribution.
Descriptive statistics and Shapiro–Wilk test results for quantitative variables in the patients who underwent closed fixation procedures with subsequent continued compression (n = 20).
| Kurt | Min | Max | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Length of hospital stay (days) | 15.05 | 11.00 | 14.42 | 2.83 | 9.77 | 4.00 | 68.00 | 0.67 | < 0.001 |
| Ilizarov treatment duration (days) | 190.85 | 169.00 | 66.61 | 0.76 | − 0.17 | 98.00 | 335.00 | 0.93 | 0.182 |
| ASAMI bone score | 9.20 | 10.00 | 2.46 | − 2.89 | 7.04 | 2.00 | 10.00 | 0.35 | < 0.001 |
| ASAMI functional score | 5.50 | 6.00 | 0.89 | − 1.25 | − 0.50 | 4.00 | 6.00 | 0.54 | < 0.001 |
| Number of complications | 0.25 | 0.00 | 0.44 | 1.25 | − 0.50 | 0.00 | 1.00 | 0.54 | < 0.001 |
M mean, Me median, SD standard deviation, Sk. skewness, Kurt. kurtosis, Min minimum, Max maximum, S–W Shapiro–Wilk test result, p-value significance of normality of distribution.
Descriptive statistics and Shapiro–Wilk test results for quantitative variables in the patients who underwent open fixation procedures with subsequent continued compression (n = 17).
| Kurt | Min | Max | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Length of hospital stay (days) | 13.88 | 11.00 | 6.97 | 1.05 | 0.41 | 4.00 | 30.00 | 0.88 | 0.030 |
| Ilizarov treatment duration (days) | 243.47 | 232.00 | 108.75 | 0.72 | 0.73 | 83.00 | 496.00 | 0.95 | 0.462 |
| ASAMI bone score | 10.00 | 10.00 | 0.00 | 0.00 | 0.00 | 10.00 | 10.00 | 0.00 | – |
| ASAMI functional score | 5.06 | 6.00 | 1.03 | − 0.13 | − 2.27 | 4.00 | 6.00 | 0.64 | < 0.001 |
| Number of complications | 0.47 | 0.00 | 0.72 | 1.27 | 0.40 | 0.00 | 2.00 | 0.68 | < 0.001 |
M mean, Me median, SD standard deviation, Sk. skewness, Kurt. kurtosis, Min minimum, Max maximum, S–W Shapiro–Wilk test result, p-value significance of normality of distribution.
Comparison of treatment results for nonunion of the tibia.
| References | Number of patients | Bone union (%) | Complications per patient |
|---|---|---|---|
| Yin et al.[ | 590 | 97.8 | |
| Peng et al.[ | 58 | 100 | 0.67 |
| Schoenleber et al.[ | 8 | 100 | 0.875 |
| Zhang et al.[ | 25 | 100 | 0.2 |
| Abuomira et al.[ | 55 | 89 | 1.2 |
| Baruah et al.[ | 50 | 98 | |
| Eralp et al.[ | 13 | 92.3 | 1.38 |
| Hosny et al.[ | 11 | 100 | 1.27 |
| Khan et al.[ | 24 | 87 | |
| Madhusudhan et al.[ | 22 | 81.8 | 2.01 |
| Magadum et al.[ | 25 | 96 | |
| Meleppuram et al.[ | 42 | 100 | 1.6 |
| Sahu et al.[ | 60 | 100 | |
| Sanders et al.[ | 19 | 84.2 | |
| Shahid et al.[ | 12 | 100 | |
| Wang et al.[ | 15 | 100 | |
| Wani et al.[ | 26 | 100 | 2.27 |
| Yin et al.[ | 65 | 100 | |
| McNally et al.[ | 79 | 73.7–96.2 | |
| Dróżdż et al.[ | 54 | 86 | |
| Marsh et al.[ | 46 | 87 | |
| Current study | 75 | 100 | 0.25–0.45 |